NCT06882031 2025-11-18Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic LeukemiaSDK Therapeutics, Inc.Phase 1 Completed12 enrolled
NCT04996030 2024-01-23A Study for Oral SY-2101 for Participants With Acute Promyelocytic LeukemiaSyros PharmaceuticalsPhase 1 Suspended16 enrolled
NCT00017433 2020-10-06Arsenic Trioxide in Treating Patients With Multiple MyelomaCTI BioPharmaPhase 2 Terminated
NCT00017069 2020-10-05Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple MyelomaCTI BioPharmaPhase 2 Terminated
NCT00020969 2020-10-05Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesCTI BioPharmaPhase 2 Terminated
NCT02066870 2015-03-13Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKIBetta Pharmaceuticals Co., Ltd.Phase 1 Unknown9 enrolled